Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviz Technologies (INVZ) Cash & Equivalents (2019 - 2025)

Innoviz Technologies' Cash & Equivalents history spans 7 years, with the latest figure at $8.6 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 65.95% year-over-year to $8.6 million; the TTM value through Dec 2025 reached $8.6 million, down 65.95%, while the annual FY2025 figure was $8.6 million, 65.95% down from the prior year.
  • Cash & Equivalents for Q4 2025 was $8.6 million at Innoviz Technologies, down from $25.4 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $55.7 million in Q4 2022 and bottomed at $8.6 million in Q4 2025.
  • The 5-year median for Cash & Equivalents is $25.4 million (2024), against an average of $27.9 million.
  • The largest annual shift saw Cash & Equivalents skyrocketed 135.69% in 2022 before it crashed 65.95% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $23.6 million in 2021, then surged by 135.69% to $55.7 million in 2022, then crashed by 52.83% to $26.3 million in 2023, then dropped by 3.49% to $25.4 million in 2024, then plummeted by 65.95% to $8.6 million in 2025.
  • Per Business Quant, the three most recent readings for INVZ's Cash & Equivalents are $8.6 million (Q4 2025), $25.4 million (Q4 2024), and $26.3 million (Q4 2023).